Bank Of America Corp Night Hawk Biosciences, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.51 $85 - $166	327 New	327 $0
Q1 2023 May 12, 2023	SELL	$0.83 - $1.24 $46 - $69	-56 Reduced 11.48%	432 $0
Q4 2022 Feb 10, 2023	BUY	$0.77 - $1.62 $43 - $90	56 Added 12.96%	488 $0
Q1 2022 May 16, 2022	SELL	$2.1 - $3.54 $100 - $169	-48 Reduced 10.0%	432 $1,000
Q4 2021 Feb 08, 2022	SELL	$3.04 - $6.01 $893 - $1,766	-294 Reduced 37.98%	480 $1,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $1,947 - $2,455	330 Added 74.32%	774 $5,000
Q2 2021 Sep 13, 2021	BUY	$5.78 - $9.6 $2,566 - $4,262	444 New	444 $3,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.